Department of Radiation Oncology, Aichi Cancer Center, Kanokoden 1-1, Chikusa-ku, Nagoya, Aichi, Japan.
Sci Rep. 2022 Aug 12;12(1):13706. doi: 10.1038/s41598-022-16583-8.
Deep inspiration breath-hold (DIBH) is widely used to reduce the cardiac dose in left-sided breast cancer radiotherapy. This study aimed to develop a deep learning chest X-ray model for cardiac dose prediction to select patients with a potentially high risk of cardiac irradiation and need for DIBH radiotherapy. We used 103 pairs of anteroposterior and lateral chest X-ray data of left-sided breast cancer patients (training cohort: n = 59, validation cohort: n = 19, test cohort: n = 25). All patients underwent breast-conserving surgery followed by DIBH radiotherapy: the treatment plan consisted of three-dimensional, two opposing tangential radiation fields. The prescription dose of the planning target volume was 42.56 Gy in 16 fractions. A convolutional neural network-based regression model was developed to predict the mean heart dose (∆MHD) reduction between free-breathing (MHD) and DIBH. The model performance is evaluated as a binary classifier by setting the cutoff value of ∆MHD > 1 Gy. The patient characteristics were as follows: the median (IQR) age was 52 (47-61) years, MHD was 1.75 (1.14-2.47) Gy, and ∆MHD was 1.00 (0.52-1.64) Gy. The classification performance of the developed model showed a sensitivity of 85.7%, specificity of 90.9%, a positive predictive value of 92.3%, a negative predictive value of 83.3%, and a diagnostic accuracy of 88.0%. The AUC value of the ROC curve was 0.864. The proposed model could predict ∆MHD in breast radiotherapy, suggesting the potential of a classifier in which patients are more desirable for DIBH.
深度吸气屏气(DIBH)广泛用于降低左侧乳腺癌放疗中心脏剂量。本研究旨在开发一种深度学习胸部 X 射线模型,用于预测心脏剂量,以选择可能存在心脏照射高风险和需要 DIBH 放疗的患者。我们使用了 103 对左侧乳腺癌患者的前后位和侧位胸部 X 射线数据(训练队列:n=59,验证队列:n=19,测试队列:n=25)。所有患者均接受保乳手术后行 DIBH 放疗:治疗计划包括三维、两个对向切线照射野。计划靶区的处方剂量为 42.56 Gy,共 16 次分割。开发了一种基于卷积神经网络的回归模型,用于预测自由呼吸(MHD)和 DIBH 之间的平均心脏剂量(∆MHD)降低。通过设定 ∆MHD>1 Gy 的截断值,将模型性能评估为二分类器。患者特征如下:中位(IQR)年龄为 52(47-61)岁,MHD 为 1.75(1.14-2.47)Gy,∆MHD 为 1.00(0.52-1.64)Gy。所开发模型的分类性能显示出 85.7%的敏感性、90.9%的特异性、92.3%的阳性预测值、83.3%的阴性预测值和 88.0%的诊断准确性。ROC 曲线的 AUC 值为 0.864。该模型可预测乳腺癌放疗中的 ∆MHD,提示该分类器具有使患者更倾向于行 DIBH 的潜力。